Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300765.SZ

STRONG SELLREMOVE

CSPC Innovation Pharmaceutical Co., Ltd. · Consumer Defensive · China · $5.0B · Avg Vol: $41M/d

3
StockRank
Q
24
V
15
M
32
P/E (TTM)
ROE
-17.0%
D/E
0.0x
Dividend %
AI CONVICTION THESIS

CSPC Innovation Pharmaceutical manufactures chemical APIs and functional food additives (primarily caffeine). It does not operate as a high-end biologics CDMO and lacks the regulatory moats, proprietary platforms, and pricing power associated with the CDMO pricing power cycle.

COMPANY DESCRIPTION

CSPC Innovation Pharmaceutical Co., Ltd. manufactures caffeine, functional food additives, and specialty pharmaceuticals, with a growing focus on oncology and cardiovascular treatments. The company is the world's largest producer of chemical synthetic caffeine, commanding a dominant global market share. It is characterized by its highly efficient, vertically integrated production facilities and its strategic transition toward high-value innovative drug development under the CSPC Group umbrella.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue388.1M375.2M292.7M318.8M-6.3%
EPS0.080.050.01-0.03-73.4%
Shares1.3B1.4B1.4B1.4B+5.1%
Debt3.0M0.2M0.1M0.8M-34.4%
Equity581.6M780.4M551.3M394.2M-12.2%
Op CF94.7M106.6M-182.5M-28.9M12.6%
Inv CF46.1M-84.4M-190.8M-50.0M
Fin CF-9.3M204.8M-58.0M62.7M
Loading...
PRICE (1Y)-25.5%
3.433.794.144.494.85May 12Jun 2Jun 23
SMA 50SMA 200
Close
$3.61
RSI (14)
42.7
52W High
$9.20
From 52W High
0.4%

SCORE BREAKDOWN

Quality
24
ROIC
-14.8%3.6
ROE
-17.0%4.7
GP/Assets
14.5%19.5
Op. Margin
-17.1%4.0
FCF/Assets
2.8%42.7
Piotroski
36.4
Int. Cover
-24.3x2.1
D/E Ratio
0.00x95.2
Current Ratio
1.00x23.1
Value
15
P/E (TTM)
N/A
EV/EBITDA
-84.3x25.0
P/FCF
1310.7x2.3
P/B
13.3x3.3
P/S
14.7x1.3
Div Yield
N/A
Momentum
32
52W High %
39%4.1
RS 6M
-36%40.6
SMA 50/200
0.80x8.8
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
94.8
Q Growth
N/A

FUNDAMENTALS

Market Cap
$5.0B
P/E (Forward)
30.2x
Gross Margin
38.5%

SECTOR PEERS

Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of 300765.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
300765.SZCSPC Innovation Pharmaceutical Co., Ltd.(you)$5.0B3STRONG SELL
600298.SSAngel Yeast Co., Ltd$4.6B26SELL
600737.SSCofco Sugar Holding CO.,LTD.$3.8B24SELL
301498.SZGambol Pet Group Co., Ltd.$2.4B20STRONG SELL
600882.SSShanghai Milkground Food Tech Co., Ltd$1.4B9STRONG SELL
002891.SZYantai China Pet Foods Co., Ltd.$1.3B10STRONG SELL
605339.SSNamchow Food Group (Shanghai) Co., Ltd.$788M2STRONG SELL
002840.SZZhejiang Huatong Meat Products Co., Ltd.$928M8STRONG SELL
002481.SZYantai Shuangta Food Co., Ltd.$722M2STRONG SELL
605179.SSZhejiang Yiming Food Co., Ltd.$801M5STRONG SELL

Peer medians: ROE 8.5% · P/E 21.3x · Gross margin 33.2%

CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ) — Stock Score Summary

CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ) has a MoatMap StockRank of 3/100 based on Quality (24/100), Value (15/100), and Momentum (32/100) factor scores. The current signal is STRONG SELL. CSPC Innovation Pharmaceutical manufactures chemical APIs and functional food additives (primarily caffeine). It does not operate as a high-end biologics CDMO and lacks the regulatory moats, proprietary platforms, and pricing power associated with the CDMO pricing power cycle.

CSPC Innovation Pharmaceutical Co., Ltd. manufactures caffeine, functional food additives, and specialty pharmaceuticals, with a growing focus on oncology and cardiovascular treatments. The company is the world's largest producer of chemical synthetic caffeine, commanding a dominant global market share. It is characterized by its highly efficient, vertically integrated production facilities and its strategic transition toward high-value innovative drug development under the CSPC Group umbrella.

Key Financial Metrics

Price$3.61
Market Cap$5.0B
P/E (Forward)30.23
Price/Book13.25
Return on Equity-17.0%
Return on Invested Capital-14.8%
Debt/Equity0.47
Gross Margin38.5%
Operating Margin-17.1%
Revenue Growth40.8%
Free Cash Flow$4M

CSPC Innovation Pharmaceutical Co., Ltd. operates in the Packaged Foods industry, part of the Consumer Defensive sector (China).

Frequently Asked Questions

What is CSPC Innovation Pharmaceutical Co., Ltd.’s (300765.SZ) StockRank?
MoatMap’s StockRank for CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ) is 3/100, with a Strong Sell signal. It is a composite of Quality (24), Value (15), and Momentum (32) factor ranks across MoatMap’s 20,000+ stock universe.
Does CSPC Innovation Pharmaceutical Co., Ltd. have an economic moat?
CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ) has a Quality factor score of 24/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is CSPC Innovation Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ) is Strong Sell, based on a StockRank of 3/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is CSPC Innovation Pharmaceutical Co., Ltd. in?
CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ) operates in the Consumer Defensive sector, specifically the Packaged Foods industry (China).